Sustainable Synthesis of Guanidine Derivatives and Computational Assessment of their Antidiabetic Efficacy

Endocr Metab Immune Disord Drug Targets. 2024 Jul 2. doi: 10.2174/0118715303287962240621053459. Online ahead of print.

Abstract

Background: Type 2 Diabetes Mellitus (T2DM) represents a significant and pressing worldwide health concern, necessitating the quest for enhanced antidiabetic pharmaceuticals. Guanidine derivatives, notably metformin and buformin, have emerged as pivotal therapeutic agents for T2DM management.

Aims: The present study introduces an efficient one-pot synthesis method for the production of symmetrical guanidine compounds.

Methods: This synthesis involves the reaction of isothiocyanates with secondary amines, employing an environmentally friendly and recyclable reagent, tetrabutylphosphonium tribromide (TBPTB).

Results: A comprehensive assessment of the biological activity of the synthesized guanidine compounds, specifically in the context of T2DM, has been rigorously conducted.

Conclusion: Additionally, computational analyses have unveiled their substantial potential as promising antidiabetic agents. Results highlight the relevance of these compounds in the ongoing pursuit of novel therapeutic solutions for T2DM.</p>.

Keywords: Guanidine; Type 2 diabetes mellitus; antidiabetic agents; compounds; computational studies; tetrabutylphosphonium tribromide; therapeutics..